Evidence map›Paper›PMID 25400499›Full record

ArticleResearch and reports in tropical medicine2014

Prevention and control of schistosomiasis: a current perspective.

Marianette T Inobaya, Remigio M Olveda, Thao Np Chau, David U Olveda, Allen Gp Ross

Open access · goldAbstract read
In one paragraph

Article in Research and reports in tropical medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 3 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 3 syntheses or guidelines pooled it, 185 citations in OpenAlex.

  1. Pooled it
  2. Interactions ofThe American journal of tropical medicine and hygiene · 2020
    Pooled it
  3. Pooled it
  4. Trial
  5. Co-infection withParasite epidemiology and control · 2026
    Article
  6. Article
  7. Prevalence ofEnvironmental health insights · 2026
    Article
  8. Article
  9. Article
  10. Evaluation of metformin's effect on the adult and juvenile stages ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. The efficacy of cercarial antigen loaded on nanoparticles as a potential vaccine candidate inJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Molluscicidal Activity of Extracts and Fractions FromJournal of parasitology research · 2024
    Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Marianette T InobayaDepartment of Health, Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
Remigio M OlvedaDepartment of Health, Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
Thao Np ChauDiscipline of Public Health, Flinders University, Adelaide, Australia.
David U OlvedaGriffith Health Institute, School of Medical Sciences, Gold Coast Campus, Griffith University, Southport, Australia.
Allen Gp RossGriffith Health Institute, School of Medical Sciences, Gold Coast Campus, Griffith University, Southport, Australia.
Research Institute for Tropical Medicine · PHFlinders University · AU

Funding

Schistosomiasis Vaccine Development and Morbidity throughout the Life CourseP50AI098481 · NIAID · RESEARCH INSTITUTE FOR TROPICAL MEDICINE · PI ACOSTA, LUZ · 2012 to 2016
$1.9M
NIAID NIH HHS P50 AI098481
6 · The paper itself

Abstract

Schistosomiasis is a neglected tropical disease that ranks second only to malaria in terms of human suffering in the tropics and subtropics. Five species are known to infect man and there are currently over 240 million people infected worldwide. The cornerstone of control to date has been mass drug administration with 40 mg/kg of praziquantel but there are problems with this approach. Human and bovine vaccines are in various stages of development. Integrated control, targeting the life cycle, is the only approach that will lead to sustainability and future elimination.

Indexed as

mass drug administrationmorbidityschistosomiaistreatment and control

Identifiers

PMID25400499
PMCPMC4231879
OpenAlexW1982014440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.